Single-cell phenotyping promises to yield insights into biological responses in heterogeneous cell populations. We developed a method based on single-cell analysis to phenotype human induced pluripotent stem cells (hIPSC) by high-throughput imaging.
Introduction
Multi-parametric analysis applied to high throughput imaging screens opened new avenues in functional genomic analysis. 1 While this method allows to measure the effect of perturbations by small molecules or small interfering RNAs (siRNAs) with cellular resolution 2, 3 , robust methods are necessary to analyse the vast amounts of multidimensional data on a single-cell level. 4, 5 Currently, most methods reduce data complexity by normalization and averaging over cell populations, thereby loosing information about phenotypic plasticity and heterogeneity within a population of perturbed cells. 6, 7 In contrast, preserving the multi-dimensionality at a single-cell level captures cell-to-cell variability and promises to provide in-depth characterization of heterogenic cell populations, such as stem cells, that are otherwise not achievable. Such analysis can be provided by multi-factorial microscopy based readout.
Human induced pluripotent stem cells (hIPSC) are an important model system to address fundamental questions in stem cell and developmental biology [8] [9] [10] , and serve as a tool to dissect disease processes using patient-derived hIPSC. The phenotypic heterogeneity of hIPSC, in particular after perturbations that might interfere with selfrenewal or initiate differentiation, requires a quantitative, single-cell analysis of hIPSCs. [11] [12] [13] Here we established a high-throughput method to comprehensively measure multi factorial phenotypes in hIPSC perturbed by RNA interference (RNAi) in order to overcome limitations for hIPSC use in high-throughput screening applications.
Results

Figure 1. Single-cell phenotyping of human induced pluripotent stem cells.
(a) Workflow of cell-based RNAi screening of hIPSC using a high-throughput microscopy read-out. (b) Representative images of hIPSC 96 hours after transfection with siRNA targeting Oct4 and non-targeting control siRNA. Bar plots show quantification of Oct4-positive and total nuclei. (c) Distinct populations of hIPSC. Each cell is represented by a dot with the following feature data: nuclear area, mean Oct4 signal intensity, and distance to first neighbour. 200 000 randomly selected cells from both, non-targeting and Oct4 targeting siRNA controls were plotted. Feature data were scaled between 0 and 1 linearly, based on the complete dataset. Colours represent populations found by k-means clustering with 6 centres and 30 random starts.
To identify modifiers of hIPSC phenotypes, we performed a kinome-wide RNAi screen using automated microscopy (Figure 1a ,b). First, we established a method to reliably seed, perturb and image hIPSC in a 384-microwell format. Transparent-bottom micro well plates were coated with Matrigel and siRNAs were pre-spotted. After treatment with ROCK-inhibitor Y27632 for 1h followed by enzymatic digestion with trypsin and collagenase IV, 2000 separated hIPSC per well were seeded and reverse transfected with siRNAs in mTeSR™ stem cell medium. We found conditions to ensure that cells were evenly distributed, spatially separated and growing robustly (Figure 2a ). After 4 days incubation, cells were fixed and stained for DNA and OCT4 protein expression. Next, we tested the gene silencing efficiency of small interfering RNAs (siRNA) targeting OCT4 (Pou5f1), a master regulator of pluripotency in hIPSC, marking cellular pluripotency state. Figure 4b ). Subsequently, a total of 1.71 Mio cells were seeded in two biological replicates. Automated imaging was performed using a robotic imaging system to acquire more than 42,000 images. We developed an image analysis pipeline for hIPSC analysis Classification into six categories resulted in the most robust clustering performance. We visualized these six reference cell categories in a 3D scatterplot (i) nuclear area, (ii) OCT4-signal intensity, and (ii) distance to first neighbour after treatment with nontargeting siRNA and siRNA targeting OCT4. OCT4 signal intensity was reduced by 80 % after OCT4 knockdown. In addition, reduction in the expression of the remaining two features could also be detected, 3.5 % and 2 % for nuclear area and distance to first neighbour, respectively (Figure 2c Even if cell count per population is normalized to total number of cells, excluding viability effects, the same trends are observed (Figure 3d ). We further validated the two candidate genes, TAF1 and SMG1, using deconvoluted pools of siRNAs. In addition, we analysed expression of additional pluripotency markers other than Oct4 after targeting TAF1 and SMG1 with siRNA. These experiments demonstrated effective gene silencing of TAF1 and SMG1 with RNAi and revealed decreased expression of NANOG and SSEA4 indicating loss of pluripotency in hIPSC after knockdown of TAF1 and SMG1 (Figure 4c ).
Conclusions
Large-scale functional analyses of heterogeneous cells have remained an unresolved challenge for high-throughput experiments. Our combined experimental and computational workflow demonstrates how image-based single-cell phenotyping could be used to identify candidate perturbations. We show how perturbation of these gene impact phenotypic characteristics of cell populations.
This indicates that cell populations undergo different functional states such as the modulation of the pluripotent state as shown in our study. Combining morphology-based features with specific markers robustly identified phenotypic classes for a heterogeneous cell type at a single-cell level. 16 Future experiments using additional markers or different control profiles may aid in the assessment of differentiation capacity of hIPSC towards specific phenotypes and help to identify perturbations that influence specific differentiation pathways.
Methods
Cell Culture
Experiments were performed in two human induced pluripotent stem cell (hIPSC) lines (hIPSC1 and hIPSC2, as indicated in Suppl. Table 1 ). hIPSC1 was derived from human skin fibroblasts (Ethics Committee of Heidelberg University approval no. 2009-350N-MA) and hIPSC2 was generated using replication-defective doxycycline-inducible single lentiviral vectors containing OCT4, KLF4 and C-MYC from primary melanocytes purchased from Promocell as described previously 1 . Reprogramming of hIPSC1 was performed using the polycistronic lentiviral vector STEMCCA-OKSM and the tet- Technologies) . To ensure pluripotency hIPSC1 were subjected to a teratoma formation assay and the expression of pluripotency markers was assessed by immunostaining (Suppl. Figure 1) .
Both, hIPSC1 and hIPSC2 were cultured in mTeSR™1 (STEMCELL Technologies) in feeder-free conditions on growth factor reduced Matrigel-coated (BD Bioscience) plates in a humidified incubator at 37° C and 5% CO 2 in standard conditions.
High-throughput siRNA screening
The kinome siRNA library (siGENOME, Dharmacon) was arrayed in growth factor reduced Matrigel (BD Bioscience) coated (20 µL per well for one hour at room temperature) 384 well micro plates (BD Bioscience) using a Biomek FX200 liquid handling system. 5 µL of a 250 nmolar siRNA pool of four single siRNAs were spotted in each well. Non-targeting single siRNA (siControl #2 in wells B4 through H4 and siRLUC in wells I4 through O4, Dharmacon) served as negative and a pool of four siRNAs targeting OCT4 (SiGenome, Dharmacon; wells B3 through H3) served as positive controls. A pool of four single siRNAs targeting UBC (SiGenome, Dharmacon; wells A3, A4, P3, and P4) served as viability controls.
For single cell seeding hIPSC were treated with 5 µmolar ROCK-inhibitor (Y27632; Axxora, 5 µmolar)) in mTeSR™1 hour before and after passaging. Cells were passaged in a two-step protocol sequentially using CTK solution consisting of 0.25% trypsin (Gibco), 0.1% collagenase IV (Invitrogen), 20% KnockOut Serum Replacement (Invitrogen) and 1 mmolar CaCl 2 as well as trypsin solution (0.25% with EDTA; Gibco)
to generate a single cell suspension. Reverse transfection was performed using Lipofectamine RNAiMAX (Invitrogen) transfection reagent. A master mix of 0.05 µL transfection reagent and 4.95 µL DMEM/F12 (Invitrogen) medium was added to each well and incubated for 20 minutes. Single hIPSC were seeded at a density of 2000 cells per well in 40µL mTeSR™1 medium supplemented with 1% penicillin/streptomycin (Invitrogen) and 5 µmolar ROCK-inhibitor. Two days after transfection 30 µL of fresh mTeSR™1 was added to each well. Plates were kept in a humidified incubator at 37° C and 5% CO 2 in standard conditions.
Fixation and Staining
Four days after transfection, cells were washed with PBS. Subsequently cells were fixed and permeabilized using 4% paraformaldehyde (Sigma) and 0.2% Triton X-100 (AppliChem) in PBS for 45 minutes at room temperature. After an additional washing step with PBS, cells were blocked with 3% BSA (Sigma) and 0.05% Triton X-100 in PBS for 45 minutes. Next, immunostaining was performed overnight at 4° C using a rabbit anti-OCT4 antibody (Abcam, working concentration 1 µg/mL) and Phalloidin-TRITC (Sigma; working concentration 1 µg/mL). After three washing steps secondary antibody staining was performed with an Alexa 488 conjugated goat anti-rabbit antibody (Invitrogen; working concentration 5µg/mL) and DNA-labelling was done with Hoechst 33242 (Invitrogen; working concentration 1µg/mL) for 1 hour at room temperature. After 4 additional washing steps plates were amenable for image acquisition.
Automated imaging
Imaging was done using an automated BD Pathway 855 Bioimaging System (Becton Dickinson) with a 20x objective (NA=0.75) in combination with a Hamamatsu digital camera (Orca-ER). 25 fields per well were imaged containing channels for Hoechst (DNA; excitation filter 380/10 nm), and FITC (Oct4; excitation filter 488/10 nm). Hoechst staining was used to bring cells into focus by laser autofocus for every single image. Due to a technical restraint of the BD Pathway microscope leading to partial duplication of image frames in row A of 384 micro well plates, all compound images had to be cropped accordingly to prevent duplicate frames to be analysed.
Image analysis
Image analysis was performed with the CellProfiler image analysis software (Version 2.0). The pipeline used in this screen is available under Suppl. Software 2. In brief, object selection was based on adaptive intensity and fixed size thresholds for every single object. Object segmentation was optimized to achieve best possible resolution of single objects in dense clusters of cells. For data analysis, morphological, intensity and spatial distribution parameters of parent objects segmented in channel 1 (Hoechst) and child objects of objects in channel 2 (Oct4) were measured.
Per-well screen analysis using cellHTS2
After manually setting a threshold for mean intensity of the Oct4 signal, cells were binned into Oct4-positive and Oct4-negative cells. The ratio of Oct4-positive nuclei (r p ) was calculated by dividing the number of Oct4-positive objects by the total number of nuclei per well. To exclude siRNAs strongly affecting cell viability, a minimum threshold t min for the cell number per well was implemented at the 5% quartile of the number of nuclei of all wells analysed for each pair of plates (plate 1: t min = 2430, plate 2: t min = 2967, plate 3: t min = 3268). The screen was analysed using the R package 
Validation Experiments
Knockdown efficiency of candidates was tested by transfecting the pools of siRNAs as well as single siRNAs (all Dharmacon; see Suppl. Table 1 for target nucleotide sequences) in hIPSC in a 96-well format. RNA from two wells of 96-well plate was isolated with the RNAeasy Mini kit (Qiagen) after 4 days of culture with conditions identical to the screen after up scaling of the respective volumes. RNA was used as template for cDNA synthesis with the Revert Aid H Minus First Strand cDNA Synthesis kit (Fermentas). Real time polymerase chain reaction was used to quantify expression of the targeted transcript using a Roche Lightcycler 480 (Roche) and the Roche Universal Probe Library (Roche). Gene expression was normalized against ACTB.
Immunofluorescence antibody staining for Oct4, SSEA4 and Nanog (all Abcam, working concentrations 1.0, 10.0 and 0.4 µg/mL, respectively) and corresponding secondary antibodies (Alexa 488 goat anti-rabbit and Alexa 594 goat anti-mouse, Invitrogen; working concentrations of 5.0 and 8.0 µg/mL, respectively) was done using the same conditions as in the screen in a 384-well format after correction of the corresponding volumes. Imaging was done using the BD Pathway 855 Imaging system (BD) as previously described for the screening experiment. Ratio (r p ) was calculated for each treatment using the above mentioned stem cell markers by dividing the number markerpositive cells by the total number of cells per well. For each experiment the mean of at least two wells for each treatment was calculated. To ensure comparability of data between individual experiments, the r p of samples was normalized to the r p of controls (non-targeting siRNA) to yield the relative ratio of marker positive cells.
